View:
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20594
SCHEDULE 13G
Under the Securities Exchange Act of 1934
(Amendment No. )*
T Cell Sciences, Inc.
(Name of Issuer)
Common Stock
(Title of Class of Securities)
872342100
(CUSIP Number)
Check the following box if a fee is being paid with this statement [ ].
(A fee is not required only if the filing person: (1) has a previous
statement on file reporting beneficial ownership of more than five
percent of the class of securities described in Item 1: and (2) has
filed no amendment subsequent thereto reporting beneficial ownership of
five percent or less of such class.) (See Rule 13d-7).
*The remainder of this cover page shall be filled out for a reporting
person's initial filing on this form with respect to the subject class
of securities, and for any subsequent amendment containing information
which would alter the disclosures provided in a prior cover page.
The information required in the remainder of this cover page shall not
be deemed to be "filed" for the purpose of Section 18 of the Securities
Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of
that section of the Act but shall be subject to all other provisions of
the Act (however, see the Notes).
1 NAME OF REPORTING PERSON
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
Capital Research and Management Company
95-1411037
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
(a)
(b)
3 SEC USE ONLY
4 CITIZENSHIP OR PLACE OF ORGANIZATION
Delaware
5 SOLE VOTING POWER
NONE
6 SHARED VOTING POWER
NUMBER OF
SHARES
NONE
BENEFICIALL
Y OWNED BY
7 SOLE DISPOSITIVE POWER
EACH
REPORTING
1,300,000
PERSON WITH
8 SHARED DISPOSITIVE POWER
NONE
9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
1,300,000 Beneficial ownership disclaimed pursuant to Rule 13d-4
10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES*
11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
5.2%
12 TYPE OF REPORTING PERSON*
IA
* SEE INSTRUCTION BEFORE FILLING OUT!
1 NAME OF REPORTING PERSON
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
SMALLCAP World Fund, Inc.
95-4253845
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
(a)
(b)
3 SEC USE ONLY
4 CITIZENSHIP OR PLACE OF ORGANIZATION
Maryland
5 SOLE VOTING POWER
1,300,000
6 SHARED VOTING POWER
NUMBER OF
SHARES
NONE
BENEFICIALL
Y OWNED BY
7 SOLE DISPOSITIVE POWER
EACH
REPORTING
NONE
PERSON WITH
8 SHARED DISPOSITIVE POWER
NONE
9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
1,300,000
10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES*
11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
5.2%
12 TYPE OF REPORTING PERSON*
IC
* SEE INSTRUCTION BEFORE FILLING OUT!
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
Schedule 13G
Under the Securities Exchange Act of 1934
Amendment No.
Item 1(a) Name of Issuer:
T Cell Sciences, Inc.
Item 1(b) Address of Issuer's Principal Executive Offices:
119 Fourth Avenue
Needham, MA 02194-2725
Item 2(a) Name of Person(s) Filing:
Capital Research and Management Company and SMALLCAP World Fund,
Inc.
Item 2(b) Address of Principal Business Office:
333 South Hope Street
Los Angeles, CA 90071
Item 2(c) Citizenship: N/A
Item 2(d) Title of Class of Securities:
Common Stock
Item 2(e) CUSIP Number:
872342100
Item 3 The person(s) filing is(are):
(d) [X] Investment Company registered under Section 8 of the
Investment Company Act.
(e) [X] Investment Adviser registered under Section 203 of
the Investment Advisers Act of 1940.
Item 4 Ownership
Capital Research and Management Company, an investment adviser
registered under Section 203 of the Investment Advisers Act of
1940 is deemed to be the beneficial owner of 1,300,000 shares or
5.2% of the 24,968,000 shares of Common Stock believed to be
outstanding as a result of acting as investment adviser to
various investment companies registered under Section 8 of the
Investment Company Act of 1940.
SMALLCAP World Fund, Inc., an investment company registered under
the Investment Company Act of 1940, which is advised by Capital
Research and Management Company, is the beneficial owner of
1,300,000 shares or 5.2% of the 24,968,000 shares of Common Stock
believed to be outstanding.
Item 5 Ownership of 5% or Less of a Class: [ ]
Item 6 Ownership of More than 5% on Behalf of Another Person: N/A
Item 7 Identification and Classification of the Subsidiary Which
Acquired the Security Being Reported on By the Parent Holding
Company: N/A
Item 8 Identification and Classification of Members of the Group: N/A
Item 9 Notice of Dissolution of the Group: N/A
Item 10 Certification
By signing below, I certify that, to the best of my knowledge and
belief, the securities referred to above were acquired in the
ordinary course of business and were not acquired for the purpose
of and do not have the effect of changing or influencing the
control of the issuer of such securities and were not acquired in
connection with or as a participant in any transaction having
such purpose or effect.
Signature
After reasonable inquiry and to the best of my knowledge and
belief, I certify that the information set forth in this
statement is true, complete and correct.
Date: July 9, 1998 (For the period ended
December 31, 1997)
Signature: *Paul G. Haaga, Jr.
Name/Title: Paul G. Haaga, Jr., Executive Vice
President
Capital Research and Management Company
Date: July 9, 1998 (For the period ended
December 31, 1997)
Signature: *Vincent P. Corti
Name/Title: Vincent P. Corti, Vice President
SMALLCAP World Fund, Inc.
*By
James P. Ryan
Attorney-in-fact
Signed pursuant to a Power of Attorney dated June 17,
1998 included as an Exhibit to Schedule 13G filed with
the Securities and Exchange Commission by Capital
Research and Management Company on July 9, 1998 with
respect to ABR Information Services, Inc.
AGREEMENT
Los Angeles, CA
July 9, 1998
Capital Research and Management Company ("CRMC"), SMALLCAP World Fund,
Inc. ("SCWF") hereby agree to file a joint statement on Schedule 13G
under the Securities Exchange Act of 1934 (the "Act") in connection with
their beneficial ownership of Common Stock issued by T Cell Sciences,
Inc.
CRMC, SCWF state that they are each entitled to individually use
Schedule 13G pursuant to Rule 13d-1(c) of the Act.
CRMC, SCWF are each responsible for the timely filing of the statement
and any amendments thereto, and for the completeness and accuracy of the
information concerning each of them contained therein but are not
responsible for the completeness or accuracy of the information
concerning the others.
CAPITAL RESEARCH AND MANAGEMENT COMPANY
BY: *Paul G. Haaga, Jr.
Paul G. Haaga, Jr., Executive
Vice President
Capital Research and Management
Company
SMALLCAP WORLD FUND, INC.
BY: *Vincent P. Corti
Vincent P. Corti, Vice
President
SMALLCAP World Fund, Inc.
*By
James P. Ryan
Attorney-in-fact
Signed pursuant to a Power of Attorney dated June 17, 1998 included
as an Exhibit to Schedule 13G filed with the Securities and
Exchange Commission by Capital Research and Management Company on
July 9, 1998 with respect to ABR Information Services, Inc.